Drug Shortage Report for SYNAGIS
| Report ID | 147957 |
| Drug Identification Number | 02438364 |
| Brand name | SYNAGIS |
| Common or Proper name | palivizumab injection |
| Company Name | ASTRAZENECA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PALIVIZUMAB |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 1 vial containing 1 mL of solution |
| ATC code | J06BB |
| ATC description | IMMUNOGLOBULINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2021-11-28 |
| Actual start date | 2021-11-28 |
| Estimated end date | 2021-12-02 |
| Actual end date | 2021-12-03 |
| Shortage status | Resolved |
| Updated date | 2021-12-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2021-12-04 | French | Compare |
| v9 | 2021-12-03 | French | Compare |
| v8 | 2021-12-03 | English | Compare |
| v7 | 2021-11-29 | French | Compare |
| v6 | 2021-11-29 | English | Compare |
| v5 | 2021-11-29 | English | Compare |
| v4 | 2021-11-10 | French | Compare |
| v3 | 2021-11-10 | English | Compare |
| v2 | 2021-10-25 | French | Compare |
| v1 | 2021-10-25 | English | Compare |
Showing 1 to 10 of 10